| Element | Current quarter | Similar quarter for previous year | % Change current | Previous quarter | % Change previous |
|---|---|---|---|---|---|
| Net profit (loss) |
18,153,482
|
42,107,726
|
-
|
-
|
-
|
| Gross profit (loss) |
191,536,243
|
181,609,833
|
5.47
|
107,804,260
|
77.67
|
| Operational profit (loss) |
20,419,647
|
42,423,798
|
-
|
-
|
-
|
| Earning or loss per share, Riyals |
0.23
|
0.53
|
-
|
-
|
-
|
| All figures are in Saudi Arabia, Riyals | |||||
| Element | EXPLAINATION |
|---|---|
| Reasons of increase (decrease) for quarter compared with same quarter last year | Net profit decrease in general due to: 1. A reduction in operating income in the Pharmaceuticals sector mainly driven by:a. Increase in Selling & Marketing expenses associated with higher salesb. increase in Research & Development expenses and General & Administration expenses2. A reduction in operating income in the Power and Steel sector mainly due to lower sales 3. An increase in financing charges.While noting that there is a decrease in other expenses mainly resulting from lower currency exchange losses in Specialty Chemicals sector, offset by the devaluation of the Egyptian Pound in the Pharmaceutical sector. |
| Reasons of increase (decrease) for quarter compared with previous quarter | Net profit increase in general due to: 1. Increase in Gross profit mainly due to the following:a. Increase in sales and higher gross profits in Pharmaceuticals and Specialty Chemicals sectors b. Lower gross losses in Power and Steel sector 2. Lower other expenses mainly resulting from lower currency exchange losses in Pharmaceutical sector |
| Reclassifications in quarterly financial results | Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period. |
| Other notes | Earnings Per Share:During the period, the Extraordinary General Assembly, in its annual meeting held on 9 Rajab 1436H (corresponding to 28 April 2015), has resolved to increase the share capital by SR 58,823,530 from the retained earnings (by issuing five bonus shares for every 63 shares held). The legal formalities have been completed. Earnings per share has been calculated for this period and comparative period of last year based on number of shares 80,000,000/- |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.